跳至主要内容
临床试验/NCT04876963
NCT04876963已完成不适用

HOLT-ED: Holter-monitoring in End-stage Renal Disease - Does Burden of Arrhythmia Assessed With Systematic Holter Electrocardiogram Monitoring Affect Cardiovascular Outcomes? - A Prospective Cohort Study

Rigshospitalet, Denmark3 个研究点 分布在 1 个国家目标入组 268 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
268
试验地点
3
主要终点
Sudden cardiac death / lethal arrhythmia

研究概览

简要总结

The main objective of this prospective cohort study is to assess arrhythmia burden and glycemic variability in a multicenter cohort of patients with end-stage renal disease using a sufficient observation period in order to identify arrhythmia burden and type and characterize associations with patient characteristics and dialysis treatment, glycemic variability and subsequent risk of adverse outcomes.

详细描述

Background: The risk of dying of a cardiovascular disease is 10-20 times increased in patients dependent on dialysis treatment compared to the general population. 1/3 of these deaths is caused by arrhythmia and 'sudden cardiac death'.

Purpose: Investigate the prevalence and type of arrhythmia in patients dependent on dialysis treatment, including the association with patient- and dialysis related factors and cardiovascular outcomes.

Methods: 7-days Holter-monitoring with Cortrium C3+ holter-monitor in 540 patients dependent on dialysis treatment in the Capital Region of Denmark. Continous blood glucose monitoring in a subgroup. 1-year follow-up via national registers.

Endpoints:

  • Prevalence of atrial fibrillation
  • Prevalence of other arrhythmia (tachycardia, bradycardia, AV-block)
  • Follow-up outcomes: sudden cardiac death, cardiovascular disease and cardiovascular death

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Dialysis-treated end-stage renal disease
  • •Age ≥ 18 years
  • •Competence to understand the study rationale necessary for written informed consent

排除标准

  • •Pre-existing pacemaker implantation

结局指标

主要结局

Sudden cardiac death / lethal arrhythmia

时间窗: 1-year follow up

Risk of sudden cardiac death or lethal arrhythmia within one year

Myocardial infarction or death attributable to myocardial infarction

时间窗: 1-year follow up

Risk of Myocardial infarction or death attributable to myocardial infarction within one year

All-cause mortality

时间窗: 1-year follow up

Risk of all-cause mortality within one year

Cardiovascular death

时间窗: 1-year follow up

Risk of cardiovascular death within one year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicholas Carlson

MD PhD

Rigshospitalet, Denmark

研究点 (3)

Loading locations...

相似试验

HOLT-ED: Holter-monitoring in End-stage Renal Disease | 临床试验